Journal Guide

Cancer Biotherapy and Radiopharmaceuticals is a peer-reviewed journal covering cutting-edge biotherapy and innovative investigations of methods to improve cancer therapy. Includes more selective delivery of drugs, biologicals, radiopharmaceuticals, and other agents, and advances in delivery instrumentation and technology, with the aim of increasing efficacy of therapy, decreasing toxicity, and/or improving convenience of therapy.Topics include:• Pre-targeted cancer therapy• Clinical trials in cancer research• Antibody therapy and imaging• Tumor cell vaccines• Radioimmunotherapy• T-cell therapy• Molecular targeted therapy and imaging• Drug resistance.

Cancer Chemotherapy and Pharmacology addresses a wide range of pharmacologic and oncologic concerns on both experimental and clinical levels. The primary focus of this rapid publication medium is on new anticancer agents, their experimental screening, preclinical toxicology and pharmacology, single and combined drug administration modalities, and clinical phase I, II and III trials. The journal publishes results recorded in the following areas: clinical toxicology, pharmacokinetics, pharmacodynamics, drug interactions, and indications for chemotherapy in cancer treatment strategy. Cancer Chemotherapy and Pharmacology is essential reading for pharmacologists and oncologists.

Designed to objectively cover the world of cardiovascular pharmacology and therapy, and to bring you the information you need most in a timely and useful format, Cardiovascular Drugs and Therapy takes a fresh and energetic look at advances in this dynamic field. Homing in on the most exciting work being done on new therapeutic agents, heart failure, hypertension and acute myocardial infarction, among others, Cardiovascular Drugs and Therapy is an authoritative source of current and relevant news that is indispensable for cardiologists seeking to best serve their patients.

Providing you with a single, concise reference tool acknowledged to be among the finest in the world, Cardiovascular Drugs and Therapy is listed in Current Contents and Index Medicus, the regular articles and frequent free supplementary issues equip you with an up-to-date source defined by the need for accurate information on an ever-changing field. Cardiovascular Drugs and Therapy is a careful and accurate guide through the maze of

Cardiovascular Therapeutics (formerly Cardiovascular Drug Reviews) focuses on extensive reviews and original articles on the treatment of cardiovascular disease. The main focus of the journal is on articles in cardiovascular pharmacology and clinical pharmacology and clinical trials of new or potential cardiovascular therapies. Articles on translational research, pharmacogenomics and personalized medicine, device, gene and cell therapies and pharmacoepidemiology are also encouraged.

Cardiovascular & Hematological Agents in Medicinal Chemistry aims to cover all the latest and outstanding developments in medicinal chemistry and rational drug design for the discovery of new Cardiovascular & Hematological Agents. Each issue contains a series of timely in-depth reviews, original research articles and drug clinical trial studies written by leaders in the field covering a range of current topics in Cardiovascular & Hematological medicinal chemistry.

Cardiovascular & Hematological Disorders-Drug Targets aims to cover all the latest and outstanding developments on the medicinal chemistry, pharmacology, molecular biology, genomics and biochemistry of contemporary molecular targets involved in cardiovascular and hematological disorders e.g. disease specific proteins, receptors, enzymes, genes. Each issue of the journal contains a series of timely in-depth, reviews, original research articles, drug clinical trial studies and guest edited thematic issues written by leaders in the field covering a range of current topics on drug targets involved in cardiovascular and hematological disorders. As the discovery, identification, characterization and validation of novel human drug targets for cardiovascular and hematological drug discovery continues to grow; this journal is essential reading for all pharmaceutical scientists involved in drug discovery and development.

Based in Basel, Switzerland, the multidisciplinary journal Cellular and Molecular Life Sciences (CMLS) publishes research articles, reviews, multi-author reviews and visions & reflections articles covering the latest aspects of biological and biomedical research. The journal will consider contributions focusing on biochemistry and molecular biology, cell biology, molecular and cellular aspects of biomedicine, neuroscience, pharmacology and immunology. In addition, CMLS welcomes comments on any article published in CMLS. Publication Schedule
One volume comprising 24 issues per year Peer Review
Of all contributions by an international board of experts Short Publication Time
Decision on acceptance/rejection within 1 month (for research articles) Online First publication; publication of the print version no more than 2 months after acceptance (for research articles) Illustrations
Black & white, color illustrations at no cost Page Charges
None

Reprints
30 complimentary reprints

Aims and Scope Download Flyer With an impact factor of 3.232 (2009).ChemMedChemon its way to become a premier journal at the interface of chemistry. biology and medicine.ChemMedChemis made in Europe. but publishes primary as well as critical secondary and tertiary information from authors across and for the world. Its mission is to integrate the wide and flourishing field of medicinal and pharmaceutical sciences. ranging from drug design and discovery to drug development and delivery. from molecular modeling to combinatorial chemistry. from target validation to lead generation and ADMET studies—to name just a few topics. Contents ChemMedChempublishes an attractive mixture of: Short Communications and Full PapersMinireviews and ReviewsHighlights and ConceptsBook and Multimedia ReviewsFields of Interest ChemMedChemtears down the walls between chemistry. biology. and medicine: drug design and discoverydrug development and deliverytarget validationlead generationADMET studiesscreeningbiological activity studiescombinatorial techniquesmolecular modelingsynthesis of biologically active compoundsmetabolism in drug actionsmolecular recognition at receptorsinteraction of ligands and receptorsapplications of NMR and X-ray crystallography ChemMedChemis accepted for coverage in MEDLINE. ISSN: 1860-7179 (print). 1860-7187 (online). CODEN: CHEMGX. Volume 6. 12 Issues in 2011. Masthead Masthead(PDF) –[Show history][Hide history] How to cite:To make sure that references to this journal are correctly recorded and resolved (for example in CrossRef or ISI Web of Science). please use the following abbreviated title in any citations: 'ChemMedChem' (punctuation may vary according to the style of the citing journal).

Chemical Biology & Drug Design is a peer-reviewed scientific journal that is dedicated to the advancement of innovative science, technology and medicine with a focus on the multidisciplinary fields of chemical biology and drug design. It is the aim of Chemical Biology & Drug Design to capture significant research and drug discovery that highlights new concepts, insight and new findings within the scope of chemical biology and drug design. The following scientific topics will exemplify the scope of the journal:.

Chemotherapy publishes original research articles and state-of-the-art reviews on all aspects of antimicrobial and antitumor chemotherapy. The results of experimental and clinical investigations into the microbiological and pharmacological properties of antibacterial, antiviral, and antitumor compounds are major topics of publication. Papers selected for the journal offer data concerning the efficacy, toxicology, and interactions of new drugs in single or combined applications. Studies designed to determine the pharmacokinetic and pharmacodynamic properties of similar preparations and comparing their efficacy are also included. Special emphasis is given to the development of drug resistance, an increasing problem worldwide.

Chinese Medicine, the official journal of the International Society for Chinese Medicine, is an open access, peer-reviewed online journal that encompasses all aspects of research on Chinese medicine, provided the material, methods, results, and conclusions are evidence-based, scientifically justified, and ethical.

The main aim of the journal is to publish scientific work on the role of molecular asymmetry in both biologically active and non-biologically active molecules in respect to their pharmacological, biological, and chemical properties. Drugs, pesticides, and other xenobiotics will be a major interest. Papers on the chemistry (physiochemical, preparative synthetic, and analytical), pharmacology, clinical pharmacology, toxicology, and other biological aspects of chiral molecules will be published. Among the topics to be covered are stereospecific synthesis, stereoselective analysis, preparative separation of chiral molecules, the influence of chirality on pharmacokinetics (absorption, distribution, protein binding, biotransformation, etc.), the influence of chirality on pharmacodynamics (drug-receptor interactions, pharmacological and toxicological activity), and the influence of chirality on clinical pharmacology (therapeutic index and response, bioavailability, adverse drug reactions, drug-drug interactions). Papers will also be published on regulatory and legal aspects in the development, testing, and marketing of chiral compounds. In addition to original research papers, the journal will publish brief reviews, short communications, and conference reports. Book reviews will also appear.

Clinical Neuropharmacology is the leading journal of reviews and original investigations in this field. The journal is devoted to the pharmacology of the nervous system in the broadest sense, with topics ranging from basic mechanisms of action, structure-activity relationships, drug metabolism, and pharmacokinetics, to such practical clinical problems as drug interactions, drug toxicity, and the therapeutics of specific syndromes or symptoms. Disorders often classified as psychiatric, as well as classical neurological disorders, are included. Website: www.clinicalneuropharm.com.

Clinical Pharmacokinetics is the major review journal in the area of clinical pharmacokinetics, the study of drug disposition in the human body, which is an integral part of drug development and rational use.